Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
RTW Biotech OpportunitiesLSE:RTW +0.41%33 3-Year Share Buyback Ratio is -15.40 as of Dec. 2025. GuruFocus rates LSE:RTW with a GF Score™ of 33/100. The stock has 2 warning signs investors should review. Among 1,136 Asset Management companies, RTW Biotech Opportunities ranks worse than 83.1% on this metric.
Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.
3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. RTW Biotech Opportunities's current 3-Year Share Buyback Ratio was -15.40%.
The historical rank and industry rank for RTW Biotech Opportunities's 3-Year Share Buyback Ratio or its related term are showing as below:
LSE:RTW'
s 3-Year Share Buyback Ratio Range Over the Past 10 Years
Min: -16.5 Med: -9.6 Max: -3.2
Current: -15.4
During the past 8 years, RTW Biotech Opportunities's highest 3-Year Share Buyback Ratio was -3.20%. The lowest was -16.50%. And the median was -9.60%.
LSE:RTW's 3-Year Share Buyback Ratio is ranked worse than 83.1% of 1136
companies
in the Asset Management industry
Industry Median: -0.8
vs LSE:RTW: -15.40
RTW Biotech Opportunities (LSE:RTW) 3-Year Share Buyback Ratio Explanation
A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.
Be Aware
Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.
RTW Biotech Opportunities 3-Year Share Buyback Ratio Related Terms
LSE:RTW vs BLK, BX, KKR: 3-Year Share Buyback Ratio Comparison
For the Asset Management subindustry, RTW Biotech Opportunities's 3-Year Share Buyback Ratio, along with its competitors' market caps and 3-Year Share Buyback Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
RTW Biotech Opportunities 3-Year Share Buyback Ratio vs Asset Management Industry
For the Asset Management industry and Financial Services sector, RTW Biotech Opportunities's 3-Year Share Buyback Ratio distribution charts can be found below:
* The bar in red indicates where RTW Biotech Opportunities's 3-Year Share Buyback Ratio falls into.
RTW Biotech Opportunities 3-Year Share Buyback Ratio Calculation
This is the annualized percentage change in shares outstanding from three years ago to the current year. The annualized percentage change is calculated with expontential compound based on the latest four years of annual data on Shares Outstanding (EOP).
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
What does a 3-Year Share Buyback Ratio of -15.40 mean?
RTW Biotech Opportunities (LSE:RTW) has a 3-Year Share Buyback Ratio of -15.40 as of Dec. 2025. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for RTW Biotech Opportunities and its competitors. According to the industry distribution chart, RTW Biotech Opportunities ranks #944 out of 1136 companies in the Asset Management industry, placing it in the top 83.1%.
Is RTW Biotech Opportunities' 3-Year Share Buyback Ratio too high?
RTW Biotech Opportunities' current 3-Year Share Buyback Ratio is -15.40. Based on the distribution chart, RTW Biotech Opportunities ranks #944 out of 1136 companies in the Asset Management industry, which is in the bottom quartile relative to peers. Overall, RTW Biotech Opportunities has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does RTW Biotech Opportunities' 3-Year Share Buyback Ratio compare to BLK and BX?
According to the Asset Management industry distribution chart, RTW Biotech Opportunities ranks #944 out of 1136 companies for 3-Year Share Buyback Ratio. This places RTW Biotech Opportunities in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Share Buyback Ratio for an Asset Management company?
A good 3-Year Share Buyback Ratio depends on the Asset Management industry context. However, 3-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Share Buyback Ratio mean?
A high 3-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for RTW Biotech Opportunities and its competitors. RTW Biotech Opportunities's current 3-Year Share Buyback Ratio is -15.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RTW Biotech Opportunities stock overvalued right now?
RTW Biotech Opportunities (LSE:RTW) has a current 3-Year Share Buyback Ratio of -15.40. The current 3-Year Share Buyback Ratio is -15.40. RTW Biotech Opportunities' overall GF Score™ is 33/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Share Buyback Ratio calculated?
3-Year Share Buyback Ratio is calculated from a company's financial statements. For RTW Biotech Opportunities (LSE:RTW), the current 3-Year Share Buyback Ratio is -15.40 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
RTW Biotech Opportunities Ltd is a life sciences and investment fund focused on identifying transformative assets with high growth potential across the biopharma and medtech sectors. It is powering medical breakthroughs that have the potential to transform the wellbeing of people around the world. Its portfolio includes Neurology, Oncology, Inflammation, Cardiovascular, Metabolic, Pulmonary, Ophthalmology, Rare Disease, and Other. Geographically it operates in USA & Canada, the Rest of World, and UK & EU, with the majority of the revenue deriving from USA & Canada.
33GF Score
Get the complete analysis for LSE:RTW
3-Year Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:RTW has been successfully added to your 
